Poor coronary collateral circulation is associated with higher concentrations of soluble adhesion molecules in patients with single-vessel disease

Coronary Artery Disease

Volumn 15, Issue 7, 2004, Pages 413-417

  Guray, Umit ^a,b   Erbay, Ali Riza ^a   Guray, Yesim ^a   Yilmaz, Mehmet Birhan ^a   Boyaci, Asiye Ayca ^a   Sasmaz, Hatice ^a   Korkmaz, Sule ^a   Kutuk, Emine ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Adhesion molecules; Collateral circulation; Coronary artery disease; Inflammation

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

COLLATERAL CIRCULATION; CORONARY CIRCULATION; CORONARY STENOSIS; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 8444226367     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200411000-00008     Document Type: Article

References (23)

1. Hansen JF. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989; 117:290-295.
2. Habib G, Heibig J, Forman S, Brown B, Roberts R, Terrin M, Bolli R. Influence of coronary collaterals on myocardial infarct size in humans: results of phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. The TIMI investigators. Circulation 1991; 83:739-746.
3. Hirai T, Fujita M, Nakajima H, Asanoi H, Yamanishi K, Ohno A, Sasayama S. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation 1989; 79:791-796.
4. Baroldi G. Coronary heart disease: significance of the morphologic lesions. Am Heart J 1973; 85:1-5.
5. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100:547-552.
6. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Ünal S, Arinç H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99:2239-2242.
7. Ito W, Arras M, Scholz D, Winkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997; 273:H1255-H1265.
8. Ito WD, Arras M, Winkler Scholz D, Winkler B, Htun P, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80:829-837.
9. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998; 82:532-539.
10. Eischen A, Vincent F, Bergerat JP, Louis B, Faradji A, Bohbot A, Oberling F. Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J Immunol Methods 1991; 143:209-221.
11. Shyy YJ, Hsieh HJ, Usami S, Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci USA 1994; 91:4678-4682.
12. Seiler C, Pohl T, Billinger M, Meier B. Tumour necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function. Heart 2003; 89:96-97.
13. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferone. J Immunol 1986; 137:1893-1896.
14. Pigott R, Dilion LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supematants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-589.
15. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-592.
16. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature 1977; 269:804-806.
17. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101:40-50.
18. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6:389-395.
19. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001; 104:2012-2017.
20. Bucay M, Nguy J, Barrios R, Chen CH, Henry PD. Impaired adaptive vascular growth in hypercholesterolemic rabbit. Atherosclerosis 1998; 139:243-251.
21. Bannan S, Mansfield MW, Grant PJ. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 1998; 41:460-466.
22. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93:1334-1338.
23. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104:1336-1342.